Sapphire Clinical Research Ltd 08872774 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is Pharmaceutical Consulting Digita Accounts Production Advanced 6.30.9574.0 true 08872774 2023-04-01 2024-03-31 08872774 2024-03-31 08872774 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 08872774 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 08872774 bus:SmallEntities 2023-04-01 2024-03-31 08872774 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 08872774 bus:AbridgedAccounts 2023-04-01 2024-03-31 08872774 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 08872774 bus:RegisteredOffice 2023-04-01 2024-03-31 08872774 bus:Director1 2023-04-01 2024-03-31 08872774 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 08872774 countries:UnitedKingdom 2023-04-01 2024-03-31 08872774 2022-04-01 2023-03-31 08872774 2023-03-31 08872774 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 08872774 core:Non-currentFinancialInstruments core:AfterOneYear 2023-03-31 iso4217:GBP xbrli:pure

Registration number: 08872774

Sapphire Clinical Research Ltd

Annual Report and Unaudited Abridged Financial Statements

for the Year Ended 31 March 2024

 

Sapphire Clinical Research Ltd

Contents

Company Information

1

Director's Report

2

Abridged Balance Sheet

3

Notes to the Unaudited Abridged Financial Statements

4

 

Sapphire Clinical Research Ltd

Company Information

Director

Ms Michelle Court

Registered office

The Barn
Cross Lane
Weston Underwood
Olney
MK46 5LD

Accountants

Quartier Ltd
7 Becket Wood
Newdigate
Dorking
Surrey
RH5 5AQ

 

Sapphire Clinical Research Ltd

Director's Report for the Year Ended 31 March 2024

The director presents her report and the abridged financial statements for the year ended 31 March 2024.

Director of the company

The director who held office during the year was as follows:

Ms Michelle Court

Principal activity

The principal activity of the company is Pharmaceutical Consulting

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the director on 3 December 2024
 

.........................................
Ms Michelle Court
Director

 

Sapphire Clinical Research Ltd

(Registration number: 08872774)
Abridged Balance Sheet as at 31 March 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

248,735

518

Current assets

 

Cash at bank and in hand

 

5,417

149,748

Prepayments and accrued income

 

74

-

Creditors: Amounts falling due within one year

(567)

-

Net current assets

 

4,924

149,748

Total assets less current liabilities

 

253,659

150,266

Creditors: Amounts falling due after more than one year

(105,948)

(5,948)

Accruals and deferred income

 

(1,402)

(1,028)

Net assets

 

146,309

143,290

Capital and reserves

 

Called up share capital

1

1

Retained earnings

146,308

143,289

Shareholders' funds

 

146,309

143,290

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the director on 3 December 2024
 

.........................................
Ms Michelle Court
Director

 

Sapphire Clinical Research Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

1

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2023 - 1).